Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Biostar, Inc. — Predicate Candidate Screening
6 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
198 daysmedian FDA review time
421 days90th percentile
6clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K991829 | CDTOX A OIA | Biostar, Inc. | 1999-11-02 | 158 | 0 |
| K991828 | STREP B OIA | Biostar, Inc. | 1999-08-19 | 83 | 0 |
| K981651 | AB FLU OIA | Biostar, Inc. | 1998-11-25 | 198 | 0 |
| K962060 | STREP A OIA MAX | Biostar, Inc. | 1997-07-23 | 421 | 1 |
| K951010 | CHLAMYDIA OIA | Biostar, Inc. | 1995-10-07 | 215 | 2 |
| K936112 | STREP B OIA | Biostar, Inc. | 1994-07-06 | 195 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda